Kyung Woo Kim

Dr. Kyung Woo Kim

National Marine Biodiversity Institute of Korea, Seoul, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
SKSun Young Kim
Sun Young Kim
YKYong Min Kwon
Yong Min Kwon
KKKyung Woo Kim
Kyung Woo Kim
JKJAOON YOUNG HWAN KIM
JAOON YOUNG HWAN KIM
Recently, there has been emerging interest in various natural products with skin protective effects as they are recognized as safe and efficient. Microalgae have developed chemical defense systems to protect themselves against oxidative stress caused by UV radiation by producing various bioactive compounds including a number of secondary metabolites, which have potential for cosmeceutical applications. In addition, microalgae have various advantages as a sustainable source for bioactive compounds with diverse functions due to their rapid growth rate, high productivity, and use of non-arable land. In this study, we aimed to investigate the cosmeceutical potential of ethanol extract from Nannochloropsis sp. G1-5 (NG15) isolated from the southern West Sea of the Republic of Korea. It contained PUFAs (including EPA), carotenoids (astaxanthin, canthaxanthin, β-carotene, zeaxanthin, violaxanthin), and phenolic compounds, which are known to have various skin protective functions. We confirmed that the NG15 extract showed various skin protective functions with low cytotoxicity, specifically anti-melanogenic, antioxidant, skin-moisturizing, anti-inflammatory, anti-wrinkling, and UV protective function, by measuring tyrosinase inhibition activity; melanin content; DPPH radical scavenging activity; expression of HAS-2, MMP-1, and Col1A1 genes; and elastase inhibition activity as well as cell viability after UV exposure. Our results indicated that the NG15 extract has the potential to be used for the development of natural cosmetics with a broad range of skin protective functions.

30 September 2024 in Marine Drugs
Verified
Journal Article
Open access
PDF file
DJDu-Min Jo
Du-Min Jo
Fazlurrahman KhanFazlurrahman Khan
Fazlurrahman Khan
SPSeul-Ki Park
Seul-Ki Park
SKSeok-Chun Ko
Seok-Chun Ko
KKKyung Woo Kim
Kyung Woo Kim
YKYoung-Mog Kim
Young-Mog Kim
To reveal potent ACE inhibitors, researchers screen various bioactive peptides from several sources, and more attention has been given to aquatic sources. This review summarizes the recent research achievements on marine peptides with ACE-inhibitory action and application. Marine peptides are considered excellent bioactives due to their large structural diversity and unusual bioactivities. The mechanisms by which these marine peptides inhibit ACE include competitive binding to ACEs’ active site, interfering with ACE conformational changes, and avoiding the identification of substrates. The unique 3D attributes of marine peptides confer inhibition advantages toward ACE activity. Because IC50 values of marine peptides’ interaction with ACE are low, structure-based research assumes that the interaction between ACE and peptides increased the therapeutic application. Numerous studies on marine peptides focused on the sustainable extraction of ACE-inhibitory peptides produced from several fish, mollusks, algae, and sponges. Meanwhile, their potential applications and medical benefits are worth investigating and considering. Due to these peptides exhibiting antioxidant, antihypertensive, and even antimicrobial properties simultaneously, their therapeutic potential for cardiovascular disease and other illnesses only increases. In addition, as marine peptides show better pharmacological benefits, they have increased absorption rates and low toxicity and could perhaps be modified for better stability and bioefficacy. Biotechnological advances in peptide synthesis and formulation have greatly facilitated the generation of peptide-based ACE inhibitors from marine sources, which subsequently offer new treatment models. This article gives a complete assessment of the present state of knowledge about marine organism peptides as ACE inhibitors. In addition, it emphasizes the relevance of additional investigation into their mechanisms of action, the optimization of manufacturing processes, and assessment in in vivo, preclinical, and clinical settings, underlining the urgency and value of this study. Using marine peptides for ACE inhibition not only broadens the repertory of bioactive compounds but also shows promise for tackling the global health burden caused by cardiovascular diseases.

16 February 2024 in Marine Drugs
Verified
Journal Article
Open access
PDF file
LDLakshi Dayarathne
Lakshi Dayarathne
SKSeok-Chun Ko
Seok-Chun Ko
MYMi-Jin Yim
Mi-Jin Yim
JLJeong Min Lee
Jeong Min Lee
JKJi-Yul Kim
Ji-Yul Kim
JJJae-Young Je
Jae-Young Je
The present study aims to explore the probable anti-adipogenesis effect of Dictyopteris divaricata (D. divaricata) in 3T3-L1 preadipocytes by regulating heme oxygenase-1 (HO-1). The extract of D. divaricata retarded lipid accretion and decreased triglyceride (TG) content in 3T3-L1 adipocytes but increased free glycerol levels. Treatment with the extract inhibited lipogenesis by inhibiting protein expressions of fatty acid synthase (FAS) and lipoprotein lipase (LPL), whereas lipolysis increased by activating phosphorylation of hormone-sensitive lipase (p-HSL) and AMP-activated protein kinase (p-AMPK). The extract inhibited adipocyte differentiation of 3T3-L1 preadipocytes through down-regulating adipogenic transcription factors, including peroxisome proliferator-activated receptor gamma (PPARγ) and CCAAT/enhancer-binding protein α (C/EBPα), and sterol regulatory element-binding protein 1 (SREBP1). This is attributed to the triggering of Wnt/β-catenin signaling. In addition, this study found that treatment with the extract activated HO-1 expression. Pharmacological approaches revealed that treatment with Zinc Protoporphyrin (ZnPP), an HO-1 inhibitor, resulted in an increase in lipid accumulation and a decrease in free glycerol levels. Finally, three adipogenic transcription factors, such as PPARγ, C/EBPα, and SREBP1, restored their expression in the presence of ZnPP. Analysis of chemical constituents revealed that the extract of D. divaricata is rich in 1,4-benzenediol, 7-tetradecenal, fucosterol, and n-hexadecanoic acid, which are known to have multiple pharmacological properties.

26 March 2018 in Macromolecular Research
Verified
Journal Article
Closed access
PDF file
KKKyung Woo Kim
Kyung Woo Kim
JLJeong Min Lee
Jeong Min Lee
YKYong Min Kwon
Yong Min Kwon
TCTae-Young Choi
Tae-Young Choi
JKJaoon Young Hwan Kim
Jaoon Young Hwan Kim
JSJong-Am Song
Jong-Am Song

Verified
Journal Article
Open access
PDF file
KKKyung Woo Kim
Kyung Woo Kim
DCDawoon Chung
Dawoon Chung
SJSeung-Hyun Jung
Seung-Hyun Jung
YKYong Min Kwon
Yong Min Kwon
JKJAOON YOUNG HWAN KIM
JAOON YOUNG HWAN KIM
KBKyunghwa Baek
Kyunghwa Baek
For several years, industrial damages caused by massive blooming and drifting of Sargassum horneri (S. horneri) called “golden tides” seaweeds have been continuously reported in Korea. National efforts have been made to produce useful cases of application by using the troublesome S. horneri. As a part of that, a CNDs–ZnO nanocomposite with antibacterial and antifungal properties was synthesized through a simple hydrothermal reaction using S. horneri, and the results were verified in this paper. The antibacterial and antifungal activities were mainly determined by the disk diffusion test against five bacterial and fungal strains, respectively. Of note, the inhibitory effect of the CNDs–ZnO on the growth of both Gram-positive (Bacillus cereus and Staphylococcus aureus) and Gram-negative (Escherichia coli, Salmonella typhimurium, and Vibrio alginolyticus) bacteria was highly effective. Moreover, the nanocomposite showed low toxicity compared to chlorine bleach. In addition, the CNDs–ZnO showed antifungal activities against both yeast (Saccharomyces cerevisiae and Rhodotorula mucilaginosa) and mold (Aspergillus flavus, Aspergillus niger, and Aspergillus terreus). This work showed the potential usability in antimicrobial application based on poor marine brown alga considered as useless in Korea. Through this paper, it seems that sufficient utility and possibility can be expected upon various unappreciated and uninterested marine species.

18 December 2024 in Marine Drugs
Verified
Journal Article
Open access
SKSun Young Kim
Sun Young Kim
HMHanbi Moon
Hanbi Moon
YKYong Min Kwon
Yong Min Kwon
KKKyung Woo Kim
Kyung Woo Kim
JKJAOON YOUNG HWAN KIM
JAOON YOUNG HWAN KIM
Nannochloropsis gaditana is well known for its potential for biofuel production due to its high lipid content. Numerous omics and biochemical studies have explored the overall molecular mechanisms underlying the responses of Nannochloropsis sp. to nutrient availability, primarily focusing on lipid metabolism. However, N. gaditana is able to synthesize other valuable products such as carotenoids, including violaxanthin, which has various biological functions and applications. In this study, we comparatively investigated the physiological, biochemical, and molecular responses of N. gaditana to nitrogen and phosphorus limitation, examining biomass production, photosynthetic activity, lipid, chlorophyll, and carotenoids content, and RNA-seq data. Nitrogen limitation decreased photosynthetic activity, chlorophyll content, and biomass production but increased lipid content. Phosphorus limitation substantially increased carotenoids content, with violaxanthin productivity of 10.24 mg/L, 3.38-fold greater than under the control condition, with little effect on biomass production or photosynthetic function. These results were generally consistent with the gene expression pattern observed in transcriptomic analysis. This integrated analysis shows that phosphorus limitation can be an economically competitive solution by enhancing valuable carotenoids while maintaining lipid and biomass production in N. gaditana.